Mark Bloomston
Regional Cancer Center · 249 works · 15,227 citations · h-index 59
Top works
- Hepatobiliary Cancers
- MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage
- MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
- IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
- Reprogramming of miRNA networks in cancer and leukemia
- Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy
- Outcome Following Bariatric Surgery in Super versus Morbidly Obese Patients: Does Weight Matter?
- Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
- Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
- The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy
- Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
- Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer
- Microwave Ablation for Hepatic Malignancies
- Predictors of Survival in Periampullary Cancers Following Pancreaticoduodenectomy
- The Value of Drains as a Fistula Mitigation Strategy for Pancreatoduodenectomy: Something for Everyone? Results of a Randomized Prospective Multi-institutional Study
- A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
- NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia